Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Itraconazole on BI 474121 Pharmacokinetics
NCT04716894Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Feb 2021
- Primary completion
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of BI 474121 in schizophrenia, sponsored by Boehringer Ingelheim. Primary endpoints: Area Under the Concentration-time Curve of BI 474121 in Plasma Over the Time Interval From 0 Extrapolated to Infinity and Maximum Measured Concentration of BI 474121 in Plasma. Started Feb 2021; status: completed.
02
Drugs
BI 474121
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT04716894.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04716894.